Journal Information
Vol. 39. Issue 1.
Pages 23-28 (January 2003)
Share
Share
Download PDF
More article options
Vol. 39. Issue 1.
Pages 23-28 (January 2003)
Full text access
Evaluación de los criterios diagnósticos clínicos de fibrosis pulmonar idiopática
Evaluation of clinical diagnostic guidelines for idiopathic pulmonary fibrosis
Visits
17345
J.L. López-Campos Bodineaua,
Corresponding author
lcampos@hcs.es

Correspondencia: Avda. Reina Mercedes, 35, 6.° D. 41012 Sevilla. España
, L. Gómez Izquierdob, E. Rodríguez Becerraa, J. Martín Juana, M. Fajardo Cascosc, F. Borderas Naranjob, J. Castillo Gómeza
a Unidad Médico-Quirúrgica de Enfermedades Respiratorias. Hospital Universitario Virgen del Rocio. Sevilla. España
b Servicio de Anatomía Patológica. Hospital Universitario Virgen del Rocío. Sevilla. España
c Servicio de Radiodiagnóstico. Hospital Universitario Virgen del Rocío. Sevilla. España
This item has received
Article information
Objetivos

Estudiar los criterios diagnósticos de la fibro-sis pulmonar idiopática según el último Consenso Interna-cional

Pacientes Y Método

Se incluyó a todos los pacientes diagnosticados de cualquier enfermedad intersticial por me-dio de biopsia pulmonar abierta desde 1980. Se revisaron sus historias clínicas para averiguar si cumplían los criterios diagnósticos, así como sus biopsias pulmonares en busca del patrón de neumonía intersticial usual. Se calcularon la sen-sibilidad, la especificidad, los valores predictivos positivo y negativo y los cocientes de probabilidad. Posteriormente, se realizó el mismo análisis requiriendo sólo una de las dos condiciones funcionales para cumplir el criterio funcional

Resultados

Se incluyó a 39 pacientes, 17 de los cuales presentaban una fibrosis pulmonar idiopática. La especifici-dad y el valor predictivo positivo fue del 100%, mientras que la sensibilidad y el valor predictivo negativo fueron del 41,2 y del 68,7%, respectivamente. El cociente de probabili-dad para un resultado negativo fue de 0,59. En el segundo análisis, la sensibilidad y el valor predictivo negativo fueron del 64,7 y del 78,5%, respectivamente, con idéntica especifi-cidad y valor predictivo positivo. El cociente de probabili-dad para un resultado negativo fue de 0,35

Conclusiones

Los criterios diagnósticos son lo suficien-temente específicos como para estar seguros del diagnóstico cuando se cumplen. Debería considerarse un pequeño cam-bio en el criterio funcional para aumentar la rentabilidad del diagnóstico

Palabras clave:
Fibrosis pulmonar idiopática
Neumonía inters-ticial usual
Diagnóstico
Objectives

To analyze the international consensus state-ment on diagnostic criteria for idiopathic pulmonary fibro-sis

Methods

All patients diagnosed of any interstitial lung disease by means of open lung biopsy since 1980 were inclu-ded. The patients' clinical records were examined to deter-mine whether they fulfilled the diagnostic criteria, and their biopsies were reviewed to find those with the usual intersti-tial pneumonia pattern. We calculated sensitivity, specifi-city, positive and negative predictive values and likelihood ratios for the diagnostic criteria in the consensus statement. Afterwards, we performed the analyses again using only one of the two conditions for fulfilling the function criterion

Results

Of 39 patients enrolled in the study, 17 had idio-pathic pulmonary fibrosis. Specificity and positive predicti-ve value were both 100%, but sensitivity was 41.2% and ne-gative predictive value was 68.7%. The likelihood ratio for a negative result was 0.59. In the second analysis, sensitivity was 64.7% and negative predictive value was 78.5%, while specificity and positive predictive value remained unchan-ged. The likelihood ratio for a negative result was 0.35

Conclusions

The criteria are sufficiently specific to allow us to diagnose confidently when the criteria are fulfi-lled. However, a slight change in the function criterion should be considered in order to increase diagnostic yield

Keywords:
Idiopathic pulmonary fibrosis
Usual interstitial pneumonia
Diagnosis
Full text is only aviable in PDF
Bibliografía
[1.]
American Thoracic Society.
Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).
Am J Respir Crit Care Med, 161 (2000), pp. 646-664
[2.]
L. Ben-noun.
Drug-induced respiratory disorders: incidence, prevention and management.
Drug Saf, 23 (2000), pp. 143-164
[3.]
J.A.D. J.r. Cooper, D.A. White, R.A. Matthay.
Drug-induced pulmonary disease. Part 1: cytotoxic drugs.
Am Rev Respir Dis, 133 (1986), pp. 321-340
[4.]
J.A.D. J.r. Cooper, D.A. White, R.A. Matthay.
Drug-induced pulmonary disease. Part 2: noncytotoxic drugs.
Am Rev Respir Dis, 133 (1986), pp. 488-505
[5.]
P. Foucher, M. Biour, J.P. Blayac, P. Godard, C. Sgro, M. Kuhn, et al.
Drugs that may injure the respiratory system.
Eur Respir J, 10 (1997), pp. 265-279
[6.]
R. Hubbard, A. Venn, C. Smith, M. Cooper, I. Johnston, J. Britton.
Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: a case-control study.
Am J Respir Crit Care Med, 157 (1998), pp. 743-747
[7.]
R. Hubbard, A. Venn, J. Britton.
Exposure to antidepressants and the risk of cryptogenic fibrosing alveolitis: a case-control study.
Eur Resp J, 16 (2000), pp. 409-413
[8.]
C.M. Fletcher, P.C. Elmes, C.H. Wood.
The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population.
Bmj, 1 (1959), pp. 257-266
[9.]
A.L.A. Katzenstein, J.L. Myers.
Idiopathic pulmonary fibrosis. Clinical relevance of pathologic classification.
Am J Respir Crit Care Med, 157 (1998), pp. 1301-1315
[10.]
I.D.A. Johnston, R.J. Prescott, J.C. Chalmers, R.M. Rudd.
British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management.
Thorax, 52 (1997), pp. 38-44
[11.]
J.H. Ryu, T.V. Colby, T.E. Hartman.
Idiopathic pulmonary fibrosis: current concepts.
Mayo Clin Proc, 73 (1998), pp. 1085-1101
[12.]
D.A. Lynch, J.D. Newell, P.M. Logan, T.E. King, N.L. Muller.
Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis?.
[13.]
E. Zerhouni, D. Naidich, F. Stitik, N.F. Khouri, S.S. Siegelman.
Computed tomography of the pulmonary parenchyma. Part 2. Interstitial disease.
J Thorac Imaging, 1 (1985), pp. 54-64
[14.]
D.B. Coultas, R.E. Zumwalt, W.C. Black, R. Sobonya.
The epidemiology of interstitial lung diseases.
Am J Respir Crit Care Med, 150 (1994), pp. 967-972
[15.]
American Thoracic Society.
Dyspnea. Mechanisms, assessment and management: a consensus statement.
Am J Respir Crit Care Med, 159 (1999), pp. 321-340
[16.]
J.E. Michaelson, S.M. Aguayo, J. Roman.
Idiopathic pulmonary fibrosis. A practical approach for diagnosis and management.
Chest, 118 (2000), pp. 788-794
[17.]
S. Murin, H.P. Wiedemann, R.A. Matthay.
Pulmonary manifestations of systemic lupus erythematosus.
Clin Chest Med, 19 (1998), pp. 641-665
[18.]
E.J. Sullivan, G.S. Hoffman.
Pulmonary vasculitis.
Clin Chest Med, 19 (1998), pp. 759-776
[19.]
L.T. Tanoue.
Pulmonary manifestations of rheumatoid arthritis.
Clin Chest Med, 19 (1998), pp. 667-685
[20.]
American Thoracic Society.
Statement on Sarcoidosis.
Am J Respir Crit Care Med, 160 (1999), pp. 736-755
Copyright © 2003. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?